As of Apr 17
| -0.01 / -0.17%|
The 2 analysts offering 12-month price forecasts for China Cord Blood Corp have a median target of 6.75, with a high estimate of 7.00 and a low estimate of 6.50. The median estimate represents a +15.58% increase from the last price of 5.84.
The current consensus among 2 polled investment analysts is to Buy stock in China Cord Blood Corp. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.